Hepatic manifestations of hereditary haemorrhagic telangiectasia
Liver International · 2024
DOI: 10.1111/liv.16008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, 2024. Verfasst von Claire Kelly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Studies, Kings College Hospital, London, UK. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Liver Transplantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Hereditary haemorrhagic telangiectasia is a genetic condition of abnormal blood vessel formation resulting from an imbalance of pro‐ and anti‐angiogenic products of the transforming growth factor β/bone morphogenetic protein signalling pathway which contributes to vascular remodelling and maintenance. Hepatic vascular malformations are common although less frequently symptomatic, but may result in high‐output cardiac failure, portal hypertension and biliary ischaemia. Whilst the understanding of the genetic and cell signalling pathways that are the hallmark of hereditary haemorrhagic telangiectasia have been clarified, there remain challenges in therapy for these patients. Only patients with symptomatic hepatic vascular malformations require treatment, with most (63%) responding to first‐line medical therapy. For non‐responders, bevacizumab is effective in reducing cardiac output in those with heart failure secondary to hepatic vascular malformations as well as other manifestations of the disease. Although liver transplantation is the only curative option, optimal timing is critical. Novel anti‐angiogenetic drugs and those that target aberrant cell signalling pathway are being explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Liver Studies, Kings College Hospital, London, UK.
- VASCERN HHT Reference Centre, ASST Maggiore Hospital, Crema, Italy.
- Department of Radiology, Kings College Hospital, London, UK.
ORCID-Profile: Claire Kelly
Zitieren
APA
Kelly, C., Buscarini, E., Manfredi, G., Gregory, S., & Heneghan, M. A. (2024). Hepatic manifestations of hereditary haemorrhagic telangiectasia. Liver International. https://doi.org/10.1111/liv.16008
Vancouver
Kelly C, Buscarini E, Manfredi G, Gregory S, Heneghan MA. Hepatic manifestations of hereditary haemorrhagic telangiectasia. Liver International. 2024. doi:10.1111/liv.16008
BibTeX
@article{Kelly2024,
author = {Kelly, Claire and Buscarini, Elisabetta and Manfredi, Guido and Gregory, Stephen and Heneghan, Michael A},
title = {Hepatic manifestations of hereditary haemorrhagic telangiectasia},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16008}
}
EUVIMED